Acetaminophen-induced hepatotoxicity: different mechanisms of acetaminophen-induced ferroptosis and mitochondrial damage
Acetaminophen-induced hepatotoxicity: different mechanisms of acetaminophen-induced ferroptosis and mitochondrial damage
复制标题
对乙酰氨基酚诱导的肝毒性:对乙酰氨基酚诱导的铁死亡和线粒体损伤的不同机制
DOI:
--
复制
发表时间:
2020
影响因子:
6.1
通讯作者:
Masafumi Takahashi
中科院分区:
文献类型:
--
作者:
Naoya Yamada;Takanori Komada;N. Ohno;Masafumi Takahashi
Accumulating evidence indicates that ferroptosis, a novel form of regulated cell death, is implicated in a wide variety of pathophysiological processes including neurodegenerative diseases, ischemia–reperfusion injury, and cancer (Conrad and Pratt 2019; Stockwell et al. 2017). We have recently found that ferroptosis driven by n-6 polyunsaturated fatty acids mediates acetaminophen (APAP)-induced acute liver failure (Yamada et al. 2020a). APAP administration induces hepatotoxicity, lipid peroxidation, and glutathione (GSH) depletion, and these were markedly suppressed by the ferroptosis-specific inhibitor Ferrostatin-1 (Fer-1), the iron chelator deferoxamine, and α-tocopherol (vitamin E), indicating that ferroptosis in hepatocytes contributes to the development of APAP-induced hepatotoxicity. Ferroptosis is known to be driven by the iron-dependent lipid peroxidation of membrane phospholipids when glutathione peroxidase 4 (GPX4) is directly or indirectly inhibited by GSH depletion (Dixon et al. 2012; Stockwell et al. 2017); however, it is still controversial which membrane of cell or organelle is responsible for lipid peroxidation during ferroptosis. Previous studies proposed that lipid peroxidation during ferroptosis can occur in plasma membrane, endoplasmic reticulum (ER), mitochondria, lysosomes, and Golgi complex (Bersuker et al. 2019; Doll et al. 2019; Feng and Stockwell 2018; Gao et al. 2019; Gaschler et al. 2018; Magtanong et al. 2018). Among them, although ferroptosis has been shown to be induced even in the cells lacking mitochondria (Gaschler et al. 2018), Gao et al. demonstrated that mitochondrial damage is important in cysteine-derivationinduced ferroptosis (i.e., GSH depletion), but not in direct GPX4 inhibition-induced ferroptosis (Gao et al. 2019). Because APAP is metabolized by the CYP2E1 and generates N-acetyl-p-benzoquinone imine (NAPQI), which binds to GSH and leads to GSH depletion (Jaeschke 2015), it is likely that mitochondria is involved in APAP-induced ferroptosis. In addition, it is generally accepted that NAPQI interacts with mitochondrial proteins and generates their adducts, which is considered to be critical for hepatotoxicity (Jaeschke 2015). To explore the involvement of mitochondria in APAPinduced ferroptosis and hepatotoxicity, we performed transmission electron microscopy (TEM) to analyze morphological change of mitochondria in hepatocytes of mice treated with APAP with or without Fer-1. Detail protocols for animal experiments and TEM were described previously (Yamada et al. 2020a, b). Briefly, overnight fasted C57BL6/J mice were injected with APAP (200 mg/kg) intraperitoneally, and the ferroptosis specific inhibitor Fer-1 or vehicle was treated 1 h prior to APAP injection. In this mouse model, serum AST and ALT elevation reached a peak at 3 h after APAP injection and severe histological damage was observed in zone 3 (centrilobular area) of the liver, and treatment with Fer-1 almost completely prevented APAP-induced elevation of serum AST and ALT. TEM showed severe mitochondrial damages in hepatocytes of mice at 3 h after APAP injection (Fig. 1). Unexpectedly, many mitochondria were enlarged and swollen in hepatocytes of APAP-injected mice treated with Fer-1. Because Fer-1 treatment prevented liver injury and lethality of mice up to 72 h after APAP injection (Yamada et al. 2020a), we assume that the hepatocytes can survive even after mitochondria are swollen. The TEM findings raise an important issue to be discussed. As mentioned above, NAPQI induces GSH depletion, leading to lipid peroxidation, presumably in the mitochondrial membrane, and subsequent ferroptosis. On the other hand, NAPQI-induced mitochondrial protein adducts * Masafumi Takahashi masafumi2@jichi.ac.jp
登录
查看更多内容
影响因子:
16
作者:
Gao, Minghui;Yi, Junmei;Jiang, Xuejun
通讯作者:
Jiang, Xuejun
影响因子:
4
作者:
Gaschler MM;Hu F;Feng H;Linkermann A;Min W;Stockwell BR
通讯作者:
Stockwell BR
影响因子:
8.6
作者:
Magtanong, Leslie;Ko, Pin-Joe;Dixon, Scott J.
通讯作者:
Dixon, Scott J.
影响因子:
9.8
作者:
Feng H;Stockwell BR
通讯作者:
Stockwell BR